Jeffrey Modell Foundation   Report issue

Foundation
Founded: New York NY United States (1987)

Organization Overview

First Clinical Trial
2019
NCT03968211
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Jeffrey Modell Foundation

Active Ingredients

Drugs in Other Trials (1)

salmonella typhi polysaccharide vaccine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1